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Abstract The pleiotropic effects of creatine (Cr) are
based mostly on the functions of the enzyme creatine
kinase (CK) and its high-energy product phosphocreatine
(PCr). Multidisciplinary studies have established molecu-
lar, cellular, organ and somatic functions of the CK/PCr
system, in particular for cells and tissues with high and
intermittent energy fluctuations. These studies include tis-
sue-specific expression and subcellular localization of CK
isoforms, high-resolution molecular structures and struc-
ture–function relationships, transgenic CK abrogation and
reverse genetic approaches. Three energy-related physio-
logical principles emerge, namely that the CK/PCr systems
functions as (a) an immediately available temporal energy
buffer, (b) a spatial energy buffer or intracellular energy
transport system (the CK/PCr energy shuttle or circuit) and
(c) a metabolic regulator. The CK/PCr energy shuttle
connects sites of ATP production (glycolysis and mito-
chondrial oxidative phosphorylation) with subcellular sites
of ATP utilization (ATPases). Thus, diffusion limitations
of ADP and ATP are overcome by PCr/Cr shuttling, as
most clearly seen in polar cells such as spermatozoa, retina
photoreceptor cells and sensory hair bundles of the inner
ear. The CK/PCr system relies on the close exchange of
substrates and products between CK isoforms and ATP-
generating or -consuming processes. Mitochondrial CK in
the mitochondrial outer compartment, for example, is
tightly coupled to ATP export via adenine nucleotide
transporter or carrier (ANT) and thus ATP-synthesis and
respiratory chain activity, releasing PCr into the cytosol.
This coupling also reduces formation of reactive oxygen
species (ROS) and inhibits mitochondrial permeability
transition, an early event in apoptosis. Cr itself may also act
as a direct and/or indirect anti-oxidant, while PCr can
interact with and protect cellular membranes. Collectively,
these factors may well explain the beneficial effects of Cr
supplementation. The stimulating effects of Cr for muscle
and bone growth and maintenance, and especially in neu-
roprotection, are now recognized and the first clinical
studies are underway. Novel socio-economically relevant
applications of Cr supplementation are emerging, e.g. for
senior people, intensive care units and dialysis patients,
who are notoriously Cr-depleted. Also, Cr will likely be
beneficial for the healthy development of premature
infants, who after separation from the placenta depend on
external Cr. Cr supplementation of pregnant and lactating
women, as well as of babies and infants are likely to be of
benefit for child development. Last but not least, Cr har-
bours a global ecological potential as an additive for ani-
mal feed, replacing meat- and fish meal for animal (poultry
and swine) and fish aqua farming. This may help to alle-
viate human starvation and at the same time prevent over-
fishing of oceans.
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Introduction
Creatine (Cr) has emerged as a safe nutritional supplement
not only to increase muscle mass and performance, prevent
disease-induced muscle atrophy and improve rehabilita-
tion, but also to strengthen cellular energetics in general
(see Salomons and Wyss 2007). The latter represents the
physiological basis for the beneficial effects of Cr supple-
mentation in the treatment of multiple pathologies that
display bioenergetic dysregulation, such as myopathies or
neurodegenerative diseases (see Andres et al. 2008).
Although Cr effects are likely due to pleiotropic cellular
functions, its main role is in the creatine kinase (CK/PCr)
system for temporal and spatial energy buffering. Inter-
disciplinary approaches in the frame of a system bioener-
getics have been successfully applied in the past and will
further be necessary to understand the CK/PCr system in
more detail (Saks et al. 2006a; Saks 2007). This review first
summarizes the fundamental knowledge that has been
accumulated on the complex CK/PCr system over the last
three decades, and in a second part gives an overview on
the pleiotropic effects of Cr related to Cr supplementation
as an adjuvant therapy in various pathologies. Exciting new
discoveries related to anti-oxidant and anti-apoptotic
effects, as well as protection of membranes by PCr are also
discussed with respect to cell protection by Cr.
The CK/PCr system for temporal and spatial buffering
and regulation of cellular energetics
Creatine and creatine kinase
Although ATP represents the universal energy currency in
all organisms and cells, ATP levels are not simply up-
regulated in cells with high and/or intermittently fluctuat-
ing energy demand. Elevation of the intracellular ATP
concentration [ATP], as an immediate energy reserve,
followed by its hydrolysis, would lead to a massive accu-
mulation of ADP plus Pi and also liberate H
?, acidifying
the cytosol. Since this would inhibit ATPases, such as the
myofibrillar acto-myosin ATPase and consequently muscle
contraction, and many other cellular processes, nature has
evolved a means to deal with the problem of the immediate
replenishment of ATP stores. The so-called phosphagens
evolved as high-energy compounds that are ‘‘metabolically
inert’’ and as such do not interfere with primary metabo-
lism. One of them, PCr, together with its corresponding
kinase, CK, first appeared at the dawn of eukaryotic evo-
lution some one billion years ago (Bertin et al. 2007).
CK catalyses the reversible reaction: PCr2 þ
MgADP + Hþ /CK  .MgATP2 + Cr and can thus
either utilize PCr (with a higher DG free energy change
than ATP) to regenerate ATP or alternatively capture
immediately available cellular energy, storing up to 10
times the amount in the ATP pool. The CK system stabi-
lizes cellular [ATP] at approximately 3–6 mM, depending
on the cell type, at the expense of [PCr], and thus maintains
the intracellular ATP/ADP ratio at a very high level and
consequently keeps the DG free energy change of ATP
hydrolysis as high as possible. This guarantees an efficient
use of ATP for all types of cellular functions; that is, the
energy gained per ATP hydrolysed is kept at a physio-
logical maximum. Resynthesis of ATP by the CK reaction,
for example upon activation of muscle contraction, also
removes ADP and H? as products of ATP hydrolysis, so
that the net product of ATPase plus the CK reaction is
liberation of Pi as a metabolic signal. Thus, the CK acts not
only acts as an energy buffer but also as a metabolic reg-
ulator (for review, see Wallimann et al. 1992, 2007).
CK isoforms and their molecular structure
CK, which is crucially involved in a plethora of bioener-
getic processes, is particularly important and is expressed
at high levels in cells with high energy requirements such
as skeletal, cardiac and smooth muscle, kidney, brain and
neuronal cells, retina photoreceptor cells, spermatozoa and
sensory hair cells of the inner ear (Wallimann et al. 1992,
2007). The most important feature for the cellular functions
of the CK/PCr system is the presence of tissue- and cell-
specific CK isoforms with defined subcellular locations.
All CK isoforms are encoded by separate nuclear genes
and, in most tissues, a single cytosolic CK isoform is co-
expressed together with a single mitochondrial CK isoform
(mtCK). Cytosolic muscle-type CK (M-CK) and brain-type
CK (B-CK) form homo–dimers or hetero-dimers, e.g. MM-
CK in skeletal muscle, MM-, MB- and BB-CK in heart, or
BB-CK in brain, kidney, spermatozoa, skin and many other
tissues. MtCK is situated in the outer mitochondrial com-
partment and occurs as sarcomeric mtCK (smtCK)
expressed mainly in muscle tissue and as ubiquitous mtCK
(umtCK) expressed in a large number of other cells and
tissues. Both form homo-dimers and homo-octamers, with
the latter being the predominant oligomeric form in vivo.
Importantly, CK isoforms are localized differentially on
a subcellular level and these specific locations are essential
for the functioning of the CK network (Wallimann et al.
1992, 2007). As for many other cellular processes, ‘‘loca-
tion, location is the name of the game’’ (Hurtley 2009). The
proposed CK/PCr energy shuttle (Wallimann 1975; Saks
et al. 1978; Bessman and Geiger 1981; Bessman 1986,
1987; Wallimann et al. 1992; Schlattner et al. 2006a, b;
Wallimann et al. 2007) connects sites of ATP production
(glycolysis and mitochondrial oxidative phosphorylation)
with subcellular sites of ATP utilization (ATPases). The
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molecular bases for this spatial energy buffering are
functionally coupled, subcellular CK micro-compartments,
at sites where ATP production and ATP consumption are
tightly connected to CK/PCr action. At these subcellular
sites, CK reactions may run in different (forward or
backward) directions, but on the global cellular or organ
level the CK system appears to be as if in equilibrium (see
Fig. 1).
The molecular structures of CK isoforms have been
solved at atomic level (Fritz-Wolf et al. 1996; Rao et al.
1998; Eder et al. 1999, 2000a; reviewed by McLeish and
Kenyon 2005) and their biochemical characteristics, e.g.
enzyme catalysis, oligomerization, membrane interaction
and binding to subcellular structures (e.g. Rossi et al. 1990;
Eder et al. 2000b; Hornemann et al. 2000; Schlattner et al.
2000; Schlattner and Wallimann 2000; Schlattner et al.
2004) and specific interaction with subcellular partners and
domains involved in such interactions (Kraft et al. 2000;
Hornemann et al. 2003) have been studied in detail over the
past decades. These studies have revealed important
aspects of structure–function relationships and molecular
physiology of CK that has allowed an understanding of the
CK/PCr system and its eminent physiological role (Schl-
attner et al. 2006a; Wallimann et al. 2007).
Temporal and spatial energy buffering
Cr derived either from endogenous synthesis in the body or
taken up from alimentary sources, e.g. meat and fish, is
transported into muscle and other target cells with high and
fluctuating energy requirements by a specific creatine
transporter (CRT) (Speer et al. 2004; Straumann et al.
2006; see Fig. 1 with respective labels and numbering used
in the following text). Imported Cr is charged to the high-
energy compound PCr by the action of either strictly
soluble, cytosolic CK (CK-c, (3)), by CK coupled to
glycolysis (CK-g, (2)) or by mtCK coupled to oxidative
phosphorylation (OP) (mtCK, (1)). In a resting cell, this
results, at equilibrium, in a distribution of the total Cr pool
into approximately two-thirds [PCr] and one-third [Cr] and
in a very high ATP/ADP ratio (C100:1). A fraction of
cytosolic isoforms of CK are specifically associated with
ATP-consuming processes (CK-a, (4)), such as the myo-
fibrillar acto-myosin ATPase, the SR Ca2?-ATPase, the
plasma membrane Na?/K?-ATPase, the ATP-gated K?-
channel or ATP-requiring constituents for cell signalling.
Within these functional micro-compartments, CK
regenerates the utilized ATP, drawing from the large PCr
pool. These micro compartments with associated CK
CRT
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Fig. 1 The CK/PCr system for temporal and spatial energy buffering
in cells of high and fluctuating energy requirements. Cr enters the
target cells via Cr transporter (CRT). Inside the cell, PCr/Cr and ATP/
ADP equilibria are adjusted by a soluble fraction of cytosolic CK
isoforms (CK-c, see (3)). Another fraction of cytosolic CK (CK-g, see
(2)) is specifically coupled to glycolytic enzymes (G), accepting
glycolytic ATP, while mitochondrial CK isoforms (mtCK, see (1)) is
coupled to adenine nucleotide translocator (ANT), thus accepting
ATP exported from the matrix and generated by oxidative phosphor-
ylation (OP). The contribution of both of these so-called microcom-
partments to total PCr generation depends on the cell type. The PCr
thus generated is fed into the large PCr pool (up to 30 mM) that is
available as a temporal or spatial energy buffer. Another fraction of
cytosolic CK (CK-a, see (4)) specifically associated with subcellular
sites of ATP utilization (ATPase, e.g. ATP-dependent or ATP-gated
processes, ion-pumps etc.) also forms tightly coupled microcompart-
ments regenerating the ATP utilized by the ATPase reaction in situ on
the expense of PCr. The proposed CK/PCr energy shuttle or circuit
connects, via highly diffusible PCr and Cr, subcellular sites of ATP
production (glycolysis and mitochondrial oxidative phosphorylation)
with subcellular sites of ATP utilization (ATPases). This model is
based on functionally coupled, subcellular CK microcompartments,
where ATP production and ATP consumption are tightly connected to
CK/PCr action (Wallimann 1975; Wallimann and Eppenberger 1985;
Schlattner et al. 2006a; Wallimann et al. 2007)
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represent the ATP/PCr-consuming side of the CK/PCr
system (4). At the ATP/PCr-generating side of the system,
there are the glycogenolytic/glycolytic CK-g microcom-
partments (2) and the mtCK microcompartment connected
to OP and energy channelling reactions inside the mito-
chondrion (1) (Schlattner et al. 2006b). MtCK is specifi-
cally located in the intermembrane space of mitochondria
with preferential access to ATP generated by OP via ade-
nine nucleotide translocator (ANT) of the mitochondrial
inner membrane. This mitochondrial ATP is trans-phos-
phorylated into PCr that then leaves the mitochondria
(Dolder et al. 2003). This route of ATP generation is most
important for refilling the PCr energy store in oxidative
tissues, e.g. upon extensive stimulation of muscle con-
traction and thus is relevant for recovery after exhausting
exercise (Quistorff et al. 1993).
A large cytosolic PCr pool of up to 30 mM is built up by
CK using ATP predominantly from OP (1) as in the heart, or
from glycolysis (2) plus OP (1) as in skeletal muscle. PCr is
then used to buffer global cytosolic (3) and local (4) ATP/
ADP ratios. This would represent the temporal buffer
function of the system. This function has been confirmed
using reverse genetic approaches. For example, by intro-
ducing a phosphagen kinase gene, the CK orthologue
arginine kinase (AK), into Escherichia coli or yeast, a
phospho-arginine pool was built up that improved recovery
of the bacteria and yeast from transient pH stress (Canonaco
et al. 2002, 2003). By a similar strategy, yeast cells into
which the genes for the enzymes for Cr biosynthesis
(AGAT and GAMT) plus CK were introduced, proved to be
resistant to metabolic stressors, such as low pH and star-
vation, by stabilizing the ATP levels during the transient
stress period to pre-stress levels (Canonaco et al. 2002).
In cells that are polarized and/or have very high or
localized ATP consumption (4), the differentially localized
CK isoforms, together with easily diffusible PCr and Cr,
maintain a high-energy PCr/Cr-circuit between ATP-pro-
viding (1, 2) and ATP-consuming processes (3, 4). Thus,
the energy producing and consuming terminals of the
shuttle are connected via PCr and Cr, with no obligatory
need for ATP or ADP to diffuse, for example, from
mitochondria (1) to the sites of ATPases (4) or backwards,
respectively. Metabolite channelling (Schlattner et al.
2011) occurs where CK is associated with ATP-providing
(1, 2) or ATP-consuming processes (4), that may be rep-
resented by ATPases, such as the actin-activated myosin
MgATPase for muscle contraction (Wallimann et al. 1984;
Ventura-Clapier et al. 1987; van Deursen et al. 1993) and
actin-based cell motility (Kuiper et al. 2009), ATP-
dependent ion-pumps and transporters, such as the SR
Ca2? pump (Rossi et al. 1990; de Groof et al. 2002), the
Na?/K?-ATPase (Guerrero et al. 1997), the gastric H?/K?-
ATPase (Sistermans et al. 1995b), as well ATP-gated ion-
channels (Dzeja and Terzic 1998), ATP-requiring meta-
bolic enzymes and protein kinases, such as AMP-activated
protein kinase (AMPK) (Ceddia and Sweeney 2004) or
Akt/PKB (Deldicque et al. 2007, 2008) involved in cell
signalling (Saks et al. 2006b; Wallimann et al. 2007).
CK in specialized polarized and epithelial cells
CK is not only prominent in sarcomeric skeletal and car-
diac muscle, where MM-CK is co-expressed with smtCK
and where these isoforms are located at specific subcellular
sites (Wegmann et al. 1992), but also in smooth muscle,
brain and other non-muscle tissues where BB-CK is co-
expressed with umtCK (Wallimann et al. 1992). For
example, BB-CK is highly expressed in spermatozoa, ret-
ina photoreceptor cells (Wallimann and Hemmer 1994) as
well as in the sensory hair cells present in the inner ear
(Shin et al. 2007). The common denominator of these cells
is that they are highly polar, elongated cells and that
mitochondria are located at a distance from intracellular
sites of ATP consumption. Therefore, these cells are the
best models to investigate how mitochondrial-generated
high-energy phosphates reach the sites of ATP consump-
tion when separated by a long diffusion distance.
CK in spermatozoa
In sea urchin sperm, 100% of the energy required for sperm
tail movement is generated in one single large mitochon-
drion located in the mid-piece behind the sperm head
(Fig. 2). Mitochondria from sea urchins and other organ-
isms harbour high concentrations of octameric mtCK
(Wallimann et al. 1986a; Tombes and Shapiro 1987; Kaldis
et al. 1996b), whereas the sperm tails contain a ‘‘cytosolic’’
CK which in sea urchins is a contiguous CK trimer (Quest
et al. 1997), but in other organisms consists of brain-type
BB-CK dimers (Wallimann et al. 1986a; Kaldis et al.
1996b). Most of the sperm tail CK is distributed along the
entire sperm tail and/or associated with the cell membrane
and the dynein ATPase (Quest et al. 1997).
In vivo experiments examining flagellar wave bending
of living sea urchin sperm, which after activation were
incubated with dinitrofluorobenzene (DNFB), a specific
inhibitor of CK, showed that increasing concentrations of
DNFB attenuated firstly flagellar wave bending, and the
amplitude of bending, at the very distal end of the sperm
tail. As DNFB concentrations were increased, flagellar
wave attenuation was gradually and progressively affected
towards the more proximal regions and the mid-piece
(Tombes et al. 1987). Similar results had been obtained with
chicken sperm (Wallimann et al. 1986a). This was a first
and very elegant visual demonstration showing that with
progressive inhibition of CK, the diffusion distances for
1274 T. Wallimann et al.
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ATP from the mitochondrion to the very end of the sperm
tail are indeed limited and that after inhibition of tail CK
they are no longer compensated for by PCr/Cr diffusion.
Using in vivo 31P-NMR saturation transfer, high-energy
phosphate concentrations as well as the rate of flux through
the CK reaction were measured before and after activation
of intact live sea urchin sperm in sea water (van Dorsten
et al. 1996, 1997), combined with concomitant measure-
ment of O2 consumption (ATP production). Knowledge of
the metabolite concentrations together with their diffusion
constants then allowed the calculation of diffusion fluxes of
the respective metabolites (Kaldis et al. 1997). As shown in
Fig. 2, PCr and Cr display a significantly higher diffusion
flux compared with ATP and ADP. Most remarkably, the
diffusion flux of ADP from the distal sperm tail end back to
the mid-piece mitochondrion is slower by three orders of
magnitude compared with Cr (Kaldis et al. 1997). Thus, the
CK/PCr shuttle is compensating for the diffusion limita-
tions of mainly ADP and somewhat less so of ATP.
CK in retina photoreceptor cells
Similar findings on the importance of the CK/PCr system
working as a spatial buffer have recently been presented for
elongated photoreceptor cells of the retina (Linton et al.
2010). CK isoforms are expressed in all cells of the retina,
but the highest levels of CK are found in the polar pho-
toreceptor cells (Wallimann et al. 1986b), where cytosolic
BB-CK and umtCK are located in the inner segments and
some BB-CK in the outer segments of the photoreceptor
cells of certain species, e.g. in bovine rod outer segments
(Wegmann et al. 1991; Hemmer et al. 1993). It was pos-
tulated that this compartmented intracellular distribution of
CK isoforms could induce an energy flux carried by the
CK/PCr system. It would emanate from the mitochondria
clustered centrally within the photoreceptor cells and
propagate in two directions, towards the synapse as well as
into the outer segment towards the photoactive membrane
stacks in the rod outer segments (Wallimann et al. 1986b).
Most recently, it has been shown by biochemical and
electrophysiological measurements that the CK/PCr system
is indeed fundamental to energy distribution in photore-
ceptors. In darkness, PCr emanating from the central
mitochondria of the photoreceptor cells flows into the
synaptic terminal, where the ATP required for sustained
glutamate release (dark current) is regenerated by cytosolic
CK that is localized at this shuttle terminal (Linton et al.
2010). Since we found BB-CK, albeit at lower levels, also
in the bovine rod outer segments (Hemmer et al. 1993), it is
conceivable that such a vectorial PCr energy transport not
head                               tail
acrosome  nucleus  mitochondrion       axoneme with dynein motor protein
5 µm
proximal mitochondrial diffusion fluxes distal dynein ATPase
[noitcudorp PTA µmol min-1g-1] ATP consumption
3 6 µmol min-1 g-1,
Pi Pi
ADP ADP
2,4
0,008
rCrC
rCPrCP
23,4
13,4
KCKCtm
PTAPTA 1,8
Fig. 2 Spatial energy buffering by the CK/PCr: the PCr/Cr-shuttle in
spermatozoa. Diffusion fluxes in sea urchin sperm were calculated
from in vivo 31P-NMR saturation transfer NMR experiments (Kaldis
et al. 1997). The diffusion flux of ADP from the sperm tail end
towards the mitochondrion located at the mid piece is more than
2,000 times slower compared with that of Cr, whereas the diffusion
flux of ATP from the region of the mitochondrion towards the sperm
tail is roughly seven times slower than that of PCr. Thus, the PCr/
Cr-shuttle is a physiological adaptation to overcome the diffusional
limitations of adenosine nucleotides, especially of ADP, to facilitate
long-distance energy transport, as well as high-throughput fluxes of
cellular energy. A similar system has been proposed and proved to
work also in the sensory hair cells of the inner ear (Shin et al. 2007)
and in the polar photoreceptor cells of the retina (Wallimann et al.
1986b; Hemmer et al. 1993; Linton et al. 2010) and in the sensory hair
cells of the inner ear (Shin et al. 2007). (Figure adapted from Kaldis
et al. 1997)
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only runs in one direction towards the synaptic terminal,
but also in the opposite direction into the rod outer seg-
ments. There, bound CK would convert PCr into ATP used
for photoreceptor signalling, that is, for stabilizing the
[ATP] needed for resynthesis of cGMP from GTP upon
photic stimulation (Hemmer et al. 1993).
Cr supply to the retina is important and seems to be
supported by a dual system: (a) by uptake from the cir-
culation via CRT expressed in the endothelial cells of the
blood/retinal barrier, and (b) by endogenous Cr synthesis
in the Mu¨ller glia cells (Tachikawa et al. 2007). Chorio-
retinal degeneration in patients with gyrate atrophy, who
present with a Cr-deficiency syndrome, can be ascribed
both to a reduced Cr supply from circulating blood and a
disrupted endogenous Cr supply to the retina from the
local Mu¨ller glia due to inhibition of Cr biosynthesis by
hyper-ornithinemia (Sipila 1980). This indicates that the
CK/PCr system is physiologically important for vision,
even though up to date no phenotype for visual defects
has been reported in transgenic CK knockout mice (see
below).
CK in hair cells of the inner ear
Brain-type cytosolic BB-CK has been also localized in the
inner ear hair cells (Spicer and Schulte 1992). CK was
identified, by a proteomic approach with isolated hair cells
from purified vestibular bundles, as the second most
prominent protein besides actin, and other proteins of the
cytoskeleton and proteins involved in Ca2? homeostasis,
stress response and glycolysis (Shin et al. 2007). Present at
a high concentration of approximately 0.5 mM inside the
sensory hair cells, the CK enzyme is capable of main-
taining constant ATP levels despite a turnover of 1 mM
ATP/s. This turnover is imposed by the plasma membrane
Ca2?-ATPase pump that maintains Ca2?-cycling during
activation of these specialized sensory cells. The polarized
hair bundle cells cannot rely on ATP diffusion and it was
shown that the CK/PCr shuttle is essential for high-sensi-
tivity hearing and vestibular function, e.g. body balance
and equilibrium. CK knockout mice presented with hearing
loss and a strong vestibular phenotype (Shin et al. 2007).
Interesting in this context is the fact that Cr supplementa-
tion of healthy wild-type mice significantly attenuates
noise-induced destruction of inner and more so of outer
hair cells and the concomitant hearing loss (Minami et al.
2007). These data indicate that the maintenance of ATP
levels by the CK/PCr system, possibly together with anti-
oxidant properties of Cr, are important for attenuating
temporary and permanent noise-induced hearing loss.
Thus, Cr supplementation may be recommended as a pre-
ventive measure in professionally noise-exposed
individuals.
CK in epithelial cells
Rather surprisingly, high concentrations of CK isoforms
were also found in a variety of epithelial cells that are not
known to have high fluctuating energy requirements, but
may need energetic support for maintaining high rates of
cell divisions, resorption or secretion activities. In stomach
epithelium parietal cells, the CK/PCr system appears to
work in conjunction with the H?/K?-ATPase pump and is
involved in gastric acid secretion (Sistermans et al. 1995b).
In epithelial cells of the intestine (Sistermans et al. 1995a)
CK may be involved in food absorption and transport, as
well as cell renewal. In skin, BB-CK and umtCK have been
localized in the keratinocytes of the highly proliferative
suprabasal layer of the epidermis, as well as in the hair
follicles and sebaceous glands (Schlattner et al. 2002),
indicating a function of the CK/PCr system for normal skin
function (Zemtsov 2007), proliferation and hair growth
(Schlattner et al. 2002). During wound healing, CK iso-
forms were highly upregulated indicating a function of CK
and Cr (Schlattner et al. 2002). In accordance with the
postulated important functions of the CK system in skin,
topical application of a Cr containing lotion directly onto
skin has been shown to exert a marked protection from
UV-induced oxidative damage and mutagenesis in vitro
(Berneburg et al. 2005) and in vivo (Lenz et al. 2005).
There is still a widely expressed concern that Cr sup-
plementation may be deleterious to the kidney. This,
unfortunately, has to do with the fact that creatine (Cr) is
still mixed-up with creatinine (Crn). Crn is the cyclic
degradation product of Cr that is generated by non-enzy-
matic conversion from Cr, until a roughly 2/3–1/3 chemical
equilibrium between Crn and Cr is established. Crn content
is measured as a kidney function marker in the serum of
patients because it is very prominent and easy to measure
chemically. While an accumulation of Crn in the serum
normally indicates that kidney function is impaired, this is
entirely unrelated to the somewhat higher serum Cr and/or
Crn concentrations during Cr supplementation which, in
this case, is not indicative of kidney malfunction or any
general toxicity. As the Crn concentration may increase
somewhat with Cr supplementation (Schedel et al. 1999),
due to the chemical equilibrium reaction between Cr and
Crn, this is often taken as a false argument for impairment
of kidney function, but in fact is a normal consequence of
Cr intake. On the contrary, CK and Cr are important for
kidney function. CK is highly expressed in kidney epithe-
lial cells (Wallimann and Hemmer 1994) and the CK/PCr
system supports Na?/K?-ATPase ion pump function in the
kidney (Guerrero et al. 1997). In addition, kidney proximal
tubule epithelial cells also express Cr transporter (CRT)
that is responsible for resorption and salvaging of Cr, a
valuable guanidino compound, from the urine (Li et al.
1276 T. Wallimann et al.
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2010). So, one may argue that if Cr would be deleterious
for the kidney, why would the kidney absorb Cr from the
urine instead of secreting it? Indeed, in a placebo-con-
trolled double-blind clinical study, involving healthy men,
Cr supplementation at 10 g/day for 3 months had no
deleterious effect on kidney function (Gualano et al.
2008b). In a single case study concerning a man with
only one kidney, who presented with a mildly decreased
glomerular filtration rate, no Cr-induced deleterious effects
of Cr supplementation (20 g/day for 30 days) were
observed (Gualano et al. 2010). Even long-term Cr sup-
plementation (4 g/day for 2 years) is today considered safe,
as seen in aged Parkinson patients (Bender et al. 2008b).
Thus, Cr taken at the recommended dosage in a chemically
pure form is not deleterious to kidney function and health.
Functions of cytosolic CK associated with glycolysis
A fraction of cytosolic CK is associated with the glycolytic
enzyme complex (Fig. 1, (2)) that, in sarcomeric muscle, is
concentrated at the myofibrillar I-band (Kraft et al. 2000). It
was shown that there, CK is specifically associated with
those glycolytic enzymes that are either involved in ATP
generation, such as pyruvate kinase (PK) (Dillon and Clark
1990; Kraft et al. 2000) or with the main regulatory enzyme
of glycolysis, phosphofructokinase (PFK), which is regu-
lated by rising [ATP] via a negative feed-back mechanism
of ATP on PFK (Kraft et al. 2000). The CK-PFK interaction
is pH-dependent and stronger at lower pH than at neutrality.
This is physiologically relevant since under conditions of
muscle activation and working glycolysis, the intracellular
pH may drop. Thus, if glycolysis is initiated immediately
after contraction to produce ATP, the close structural and
functional association of CK with distinct members of the
glycolytic micro-compartment makes sense in two ways:
(a) glycolytic ATP is immediately removed from this
compartment by associated CK and thus inhibition of gly-
colysis by negative feed-back regulation via ATP accu-
mulation is prevented, and (b) glycolytic ATP can be used
concomitantly to reduce the depletion of the PCr pool
during contraction (Kraft et al. 2000; Wallimann et al.
2007). The principle of tight functional coupling of gly-
colysis to CK action has been shown in vitro in a system of
reconstituted glycolysis containing CK (Scopes 1973) and
also in vivo in an anoxic goldfish model (van den Thillart
et al. 1989) where mitochondrial function is basically
eliminated due to lack of oxygen. There, clearly, glycolytic
ATP was shown to be used to replenish the PCr pool,
although not to the maximal extent (van den Thillart et al.
1989; Van Waarde et al. 1990).
The coupling of CK to the glycogenolytic/glycolytic
pathway is also supported by gated 31P-NMR measure-
ments following at very high time-resolution the metabolite
fluctuations elicited by single muscle contractions (Chung
et al. 1998). After a single contraction the recovery of PCr
is much faster than at the end of stimulation. This implies a
distinct recovery mechanism in the first phase, which is in
line with the contention that a significant proportion of
glycogenolytic/glycolytic ATP is immediately used and
trans-phosphorylated by CK to replenish PCr (see also
Shulman 2005). After the end of stimulation, however, PCr
recovery kinetics is consistent with a predominant role of
OP (van den Thillart et al. 1989; Van Waarde et al. 1990;
Quistorff et al. 1993; Chung et al. 1998). Finally, trans-
genic CK knock-out mice show an altered glycolytic net-
work in their CK-deficient muscles (de Groof et al. 2001a),
which also indicates an intricate interconnection of the two
systems. This is corroborated by the fact that muscles of
PFK-deficient patients show a dramatic delay in PCr
recovery following exercise (Grehl et al. 1998).
Functions of mitochondrial CK (mtCK)
Metabolite channelling in the mtCK microcompartment
After the import of nuclear encoded, nascent mtCK through
the mitochondrial outer membrane and cleavage of the
N-terminal targeting sequence, mtCK first assembles into
dimers. These dimers rapidly associate into octamers and
although this reaction is reversible, octamer formation is
strongly favoured by the high mtCK concentration in the
inter-membrane space (Schlattner et al. 2006a). The sym-
metrical and cube-like mtCK octamers (Fritz-Wolf et al.
1996; Eder et al. 2000a) then directly bind to acidic
phospholipids in the mitochondrial membranes (Fig. 3),
preferentially to cardiolipin of the inner mitochondrial
membrane (Schlattner et al. 2004), and in a calcium-
dependent manner directly to VDAC (Schlattner et al.
2001). Affinity of both ANT and mtCK for cardiolipin sit-
uates them in common cardiolipin patches (Fig. 3), which
can also be induced by membrane-bound mtCK (Epand
et al. 2007b), thus allowing for a functional interaction
between both proteins (Wallimann et al. 1998; Schlattner
et al. 2006b). MtCK is found in two locations (Wegmann
et al. 1991): (a) in the so-called mitochondrial contact sites
(Fig. 3), where mtCK simultaneously binds to inner and
outer membrane due to its symmetrical octameric structure
(see below) and where it functionally associates with ANT
and VDAC (Kottke et al. 1991) and (b) in the cristae (not
shown) associated with inner membrane and ANT only
(Wegmann et al. 1991; for details, see Schlattner et al.
2006a, 2011). A well-coupled MtCK micro compartment is
also maintained by diffusion restrictions for adenylates at
the outer membrane VDAC, possibly via direct interaction
of VDAC with tubulin (Rostovtseva et al. 2008). The
preferred or exclusive substrate and product fluxes in a
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well-coupled mtCK microcompartment are indicated in
Fig. 3 by black arrows (Saks et al. 2000); minor or alter-
native fluxes at a lower degree of coupling are shown with
blue arrows.
According to this scheme, ATP generated by OP via the
F0F1-ATPase is transported through the inner membrane by
ANT in exchange for ADP. This ATP may either leave the
mitochondrion directly via outer membrane VDAC or is
preferentially accepted and trans-phosphorylated into PCr
by octameric mtCK in the intermembrane space. PCr then
preferentially leaves the mitochondrion via VDAC and
feeds into the large cytosolic PCr pool. ADP generated
from the mtCK trans-phosphorylation reaction is accepted
by ANT and immediately transported back into the matrix
to be recharged. In contact sites, this substrate channelling
allows for a constant supply of substrates and removal of
products at the active sites of mtCK. In cristae, only ATP/
ADP exchange is facilitated through direct channelling to
the mtCK active site, while Cr and PCr have to diffuse
along the cristae space to reach VDAC (not shown; for
Fig. 3 Mitochondrial mtCK functions for high-energy metabolite
channelling in mitochondria. In cells with oxidative metabolism,
respiration (green arrow), ATP synthesis and ATP export through the
inner mitochondrial membrane via adenine nucleotide transporter
(ANT) are tightly coupled to trans-phosphorylation of ATP to PCr by
mtCK and export of PCr into the cytosol by the outer membrane
voltage-dependent anion channel (VDAC) as indicated by black
arrows. In turn, Cr stimulates respiration by favoring constant supply
of ADP to the matrix (black arrows), which also lowers ROS/RNS
production in the intra-mitochondrial space (red arrows) and inhibits
mitochondrial permeability transition. The tight coupling of substrate
and product fluxes (black arrows) allows a so-called channeling of
‘‘high-energy’’ metabolites, with PCr being the one released into the
cytosol, and ATP/ADP being mainly recycled within the
mitochondria. The structural basis of these mtCK microcompartments
are proteolipid complexes containing either VDAC, octameric mtCK
and ANT in the peripheral intermembrane space (as shown) or
octameric mtCK and ANT in the cristae (not shown). These
proteolipid complexes are maintained by mtCK interactions with
anionic phospholipids and VDAC in the outer membrane, and with
cardiolipin and thus indirectly with cardiolipin-associated ANT in the
inner membrane (see cardiolipoin patches). In cases of a less coupled
mtCK microcompartment, e.g. after impairment of mtCK function by
oxidative damage, there is partial direct ATP/ADP exchange with the
cytosol (blue arrows). (Figure adapted from Kaldis et al. 1997; Meyer
et al. 2006; Schlattner et al. 2006a; Schlattner et al. 2011) (The
different fluxes are indicated by coloured arrows in the figure)
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details, see Schlattner et al. 2006a, b; Wallimann et al.
2007).
Functional coupling of ANT to mtCK leads to a satu-
ration of mtCK with ANT-delivered ATP, and at the same
time to a locally high ATP/ADP ratio in the vicinity of
mtCK. In combination with cytosolic Cr, entering the
intermembrane space via VDAC, these conditions are
favourable to drive the synthesis of PCr from ATP by
mtCK without loss of energy content. This maintains
maximal thermodynamic efficiency for high-energy phos-
phate synthesis and channelling, which in the form of PCr
is exported into the cytosol (Dolder et al. 2003). Such a
reaction sequence represents an instructive example of
functional coupling and metabolite channelling. The active
ATP/ADP exchange maintained by coupled mtCK favours
ATP generation by the F0F1-ATPases and thus proper
functioning of the respiratory chain, which could otherwise
generate elevated levels of superoxide and reactive oxygen
species (ROS) (Schlattner et al. 2011).
The intricate functional coupling of mtCK to the ANT
(Vendelin et al. 2004), leading to a saturation of the ANT
on the outer site of the inner membrane with ADP, which
then is transported back into the matrix to be recharged by
the F0F1-ATPase, efficiently couples substrate oxidation to
ATP generation. Such tight coupling, by avoiding futile
electron transfer, conceivably also would lower the pro-
duction of free oxygen radicals (ROS). Indeed, mitochon-
drial respiration in the presence of Cr needs only
micromolar concentrations of ADP to be fully stimulated,
whereas in the absence of Cr comparably high concentra-
tion of ADP in the millimolar range are needed for a
similar respiratory rate (Kay et al. 2000; Saks et al. 2000).
This important phenomenon, termed ‘‘creatine-stimulated
respiration’’ is entirely dependent on the presence of mtCK,
for mitochondrial respiration can no longer be stimulated
by Cr in intact chemically skinned muscle fibres or mito-
chondria isolated from cardiac or skeletal muscle of smtCK
knockout mice (Kay et al. 2000). Finally, Cr exerts a strong
indirect anti-oxidant effect by significantly reducing the
intra-mitochondrial production of ROS, as well as elevat-
ing and preserving the mitochondrial membrane potential
(Meyer et al. 2006). These Cr-meditated events may rep-
resent the basis for some of the remarkable neuro-protec-
tive effects of Cr that had been discovered recently
(reviewed by Andres et al. 2008).
MtCK and mitochondrial membranes
Both, sarcomeric smtCK (Fritz-Wolf et al. 1996) and
ubiquitous umtCK (Eder et al. 2000a) show cube-like oc-
tameric structures of mtCK with approximately 100 A˚ side
lengths, built by four identical mtCK dimers that are
arranged by fourfold symmetry around a central channel of
approximately 20 A˚ in diameter. These octamers maintain
multiple and complex interactions with the phospholipids
of the mitochondrial membranes (reviewed by Schlattner
et al. 2006b). By their identical top and bottom faces,
which each expose four C-termini, MtCK binds strongly to
anionic phospholipids, in particular cardiolipin that is
abundant in the inner mitochondrial membrane. By virtue
of their molecular symmetry, mtCKs are also able to cross-
link two membranes. Both membrane-binding and cross-
linking characteristics of mtCK have been thoroughly
investigated and quantified by a number of biophysical
techniques (Rojo et al. 1991; Stachowiak et al. 1996, 1998;
Schlattner et al. 2004). By site-directed mutagenesis, a
cluster of positively charged amino acids at the C-termini
has been identified as responsible for mtCK’s ability to
specifically attach to cardiolipin-containing membranes
(Schlattner et al. 2004; Schlattner et al. 2006a). Binding of
mtCK with mitochondrial membranes takes place in two
phases (Schlattner et al. 2004). The first phase of mtCK
attachment is mediated by ionic interaction by positively
charged amino acid clusters at the C-terminal of mtCK; the
second slower phase is mediated by partial insertion of a
hydrophobic stretch into the membrane bilayer (Schlattner
et al. 2006a; Maniti et al. 2010). The ability of mtCK to
bind to and cross-link two membranes explains the contact
site formation between mitochondrial inner and outer
membranes and the resulting mechanical stabilization of
mitochondria as shown with liver mitochondria from
transgenic mice expressing mtCK (Speer et al. 2005). Also,
the formation of the characteristic crystalline intra-mito-
chondrial ‘‘railway-track’’ inclusions, built of mtCK octa-
mers (Stadhouders et al. 1994) inside of mitochondria of
‘‘ragged red fibres’’ from patients with mitochondrial cyt-
opathies, can be explained by membrane binding of mtCK
octamers either peripherally between inner and outer
membrane or in the cristae between inner membranes.
Once bound to membranes, mtCK shows a pronounced
tendency to form ordered 2D crystalline arrangements
(Schnyder et al. 1994). These resemble the sheet-like
crystalline inclusions in such patient’s mitochondria
(Stadhouders et al. 1994). Interestingly, these pathological
intra-mitochondrial mtCK crystals that are formed as a
result of a compensatory over-expression reaction to an
energy deficit (O’Gorman et al. 1997b), can also be
induced after Cr depletion in adult cardiomyocytes by
addition of guanidine propionic acid (GPA) (Eppenberger-
Eberhardt et al. 1991). These mtCK inclusions, both in Cr-
depleted cardiomyocytes and in mitochondrial myopathy
patients, disappear upon Cr supplementation of the cell
culture medium or the patients, respectively (Eppenberger-
Eberhardt et al. 1991; Tarnopolsky et al. 2004). Finally,
recent data show that mtCK, once bound to cardiolipin-
containing membrane vesicles, is able to specifically
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cluster cardiolipin molecules around its molecular surface
(Epand et al. 2007b) and, if cross-linked to a second
membrane vesicle, mtCK is able to facilitate lipid
exchange between the two membranes (Epand et al.
2007a). This of course seems relevant for the structure and
physiology of mitochondrial inner/outer membrane contact
sites and the pre-apoptotic process of mitochondrial per-
meability transition pore (MPTP) function.
Control of mitochondrial permeability transition,
stabilization of inner/outer mitochondrial membrane
complex and anti-apoptotic effects of creatine
As mentioned earlier, mtCK occupies strategically impor-
tant dual locations in the intermembrane and the cristae
space (Kottke et al. 1991). In the periphery of the mito-
chondrion, mtCK is part of a protein complex that is
involved in the so-called mitochondrial permeability tran-
sition (MPT) pore complex (O’Gorman et al. 1997a; Dolder
et al. 2003). Although the molecular composition of
the pore remains an open question, it seems to involve the
adenine nucleotide transporter ANT-1 isoform and the
voltage-dependent anion carrier VDAC (Zhivotovsky et al.
2009) together with mtCK (Kroemer et al. 2007). MPT
represents an early event in apoptosis that often leads to
swelling of mitochondria and release of apoptosis-inducing
factors that can be initiated experimentally by exposure of
mitochondria to atractyloside, an inhibitor of ANT, and/or
by elevation of extra-mitochondrial [Ca2?] (Azzolin et al.
2010). Under these conditions, isolated mitochondria from
the liver of normal wild-type mice, which do not express
mtCK in the liver, undergo swelling and apoptosis. This
process can be inhibited by cyclosporine, a potent anti-
apoptotic drug. On the other hand, transgenic mice that have
been engineered to express mtCK in their liver are protected
from apoptosis and its destructive consequences by simple
addition of Cr or its analogue cyclocreatine that is also
phosphorylated by the CK reaction (Fig. 4). The extent of
protection by Cr is comparable to that of cyclosporine
(Dolder et al. 2003). Thus, Cr is not only involved in
stimulating mitochondrial respiration but also works as an
effective mitochondrial protectant and anti-apoptotic com-
pound (Brdiczka et al. 2006). This may explain some of the
cell-protective effects observed with Cr. For example,
transgenic mice expressing mtCK in their liver acquire,
after Cr supplementation, a remarkable tolerance against
hypoxia (Miller et al. 1993) and liver toxins (Hatano et al.
1996), as well as against tumour necrosis factor-induced
apoptosis (Hatano et al. 2004). Since PCr has been shown to
bind to and protect biological membranes (Saks et al. 1996;
Tokarska-Schlattner et al. 2003, 2005a), it is conceivable
that the PCr generated by mtCK in the mitochondrial inter-
membrane space would also bind to mitochondrial
membranes and stabilize them against swelling, as this was
shown for plasma membranes of erythrocytes (Tokarska-
Schlattner et al. 2003, 2005a). Thus, mtCK plus Cr seem to
exert cell protection not only by improving cellular ener-
getics, but also by more or less energy-independent actions
that also affect apoptosis (O’Gorman et al. 1997a; Brdiczka
et al. 2006) (see Table 1).
Phenotypes of CK knockout mice point to important
cellular functions of CK and the PCr/Cr system
Ablation of a given gene in transgenic knockout animals is
a valuable tool to possibly evaluate the functions of this
specific gene, or the respective protein coded by this gene,
in an animal. The various constitutive CK knockouts,
engineered by the Wieringa Group in Nijmegen NL,
illustrates the phenotypical defects caused by the deletion
of CK. Ablation of smtCK in muscle is a good example for
a positive identification of a CK function. The fact that
mtCK is required for stimulation of mitochondrial respi-
ration by Cr (Saks et al. 2000) has been unambiguously
corroborated by this technology with mtCK-deficient or
double CK knockout mice (Kay et al. 2000).
Adaptation and compensation effects alter knockout
phenotypes
Gene ablation may lead to complex adaptations in the
organism to compensate for the loss of function related to
the knocked out gene. Some very interesting compensatory
events take place in the absence of CK function. In the
Fig. 4 Mitochondrial permeability transition is inhibited by CK
substrates. At a concentration of 10 mM, the CK substrates creatine
(Cr) and cyclocreatine (cCr), Cr-analogon, inhibit MTP in isolated
mouse liver mitochondria to a comparable degree as 1 lM cyclo-
sporin A (CSA), the gold standard for MPT inhibition (Dolder et al.
2003). The Cr-analogon guanidinopropionic acid (GPA) that is not
accepted as a substrate by the CK reaction has no effect as compared
to control without additions (none). Isolated liver mitochondria from
transgenic mice expressing uMtCK in their liver were analysed by a
swelling (light scattering) assay. They were energized with glutamate/
malate in presence of 2mM Mg2? and then challenged by 120 lM
Ca2? where indicated. (Figure taken from Dolder et al. 2003 with
permission)
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constitutive CK knockouts, this may lead to a physiological
and phenotypical amelioration of the phenotype, thus often
hindering the phenotypic expression of a dysfunction
related to CK deletion. As an example for phenotypic
compensation, knocking out of CK in muscle leads to
marked changes in mRNA expression profiles involving
nuclear and mitochondrial mRNA species that are relevant
for bioenergetics (de Groof et al. 2001b), as well as to
altered expression of proteins involved in the glycolytic
network and mitochondria (de Groof et al. 2001a). Double
knock-out of cytosolic and smtCK in muscle also leads to
remarkable compensatory adaptation of muscle structure
and metabolism, e.g. in white, glycolytic Type II muscle
fibres, which normally do not contain large numbers of
mitochondria, the CK double knockout animals show a
vastly increased mitochondrial propensity and a position-
ing of these large numbers of mitochondria in such a way
that each myofibril is almost completely surrounded by
contiguous rows of mitochondria. Thus, these transgenic
‘‘glycolytic’’ muscle fibres look rather like entirely oxida-
tive insect flight muscle (Veksler et al. 1995; Ventura-
Clapier et al. 1995; Steeghs et al. 1998; Ventura-Clapier
et al. 2004; Novotova et al. 2006). This points to a com-
pensation in the CK knockouts for reducing diffusion dis-
tances for ATP from the mitochondria to the contractile
apparatus and thus would support the proposed function of
the PCr shuttle that normally compensates for the diffusion
limitations of adenine nucleotides via shuttling of PCr and
Cr. This notion is fully supported by detailed analysis of
energy provision in CK knockouts, e.g. by the propinquity
of mitochondria to myofibrils enabling ATP/ADP to be
channelled directly from mitochondria to myofibrils and
back (Kaasik et al. 2003). In addition, the glyocogen
content in these muscles is elevated indicating that instead
of PCr, glycogen/glucose is taken as a more or less
immediate source of energy for muscle contraction. Such
Table 1 Pleiotropic effects of creatine for cell function and cell protection
Energy-related effects of creatine
Cr improves cellular energy state (PCr/ATP ratio) and muscle performance (Harris et al. 1992; Greenhaff et al. 1993)
Cr facilitates intracellular energy transport (PCr circuit or shuttle) (Wallimann 1975; Saks et al. 1978, 2006b;
Bessman and Geiger 1981; Wallimann and Eppenberger
1985; Bessman 1986; Wallimann et al. 1992, 1998;
Kaasik et al. 2003; Wallimann et al. 2007)
Cr improves the efficiency of cellular energy utilization
(e.g. for Ca2?-handling)
(Rossi et al. 1990; Steeghs et al. 1997; Pulido et al. 1998;
van Leemputte et al. 1999)
Cr stimulates mitochondrial respiration (improved energy provision) (Kay et al. 2000; Meyer et al. 2006)
Cr stabilizes mitochondrial PTP complex and thus acts as mitochondrial
protectant (anti-apoptotic)
(O’Gorman et al. 1997a; Dolder et al. 2003;
Hatano et al. 2004)
Anti-oxidant and anti-apoptotic effects of creatine
Cr acts as a mild direct anti-oxidant (free radical scavenger) (Lawler et al. 2002)
Cr acts as a strong indirect anti-oxidant in mitochondria
(where ROS production is lowered by tight coupling of respiration/ATP
production to ATP export)
(Meyer et al. 2006; Sestili et al. 2006)
Cr reduces oxidative damage to DNA, specifically to mtDNA (Guidi et al. 2008)
Cr up-regulates enzymes for oxidative stress defence (Young et al. 2010)
Cr strongly protects in vivo from mitochondrial toxins (Rotenone & Paraquat) (Hosamani et al. 2010)
Cr stabilizes mitochondrial PTP complex and thus acts as mitochondrial
protectant (anti-apoptotic)
(O’Gorman et al. 1997a; Dolder et al. 2003; Hatano et al. )
Other effects of creatine
Cr induces differential expression of transcription factors and other genes (Hespel et al. 2001; Louis et al. 2004;
Deldicque et al. 2008; Safdar et al. 2008)
Cr reduces the appearance of inflammation markers
during endurance exercise
(Santos et al. 2004; Bassit et al. 2008)
Cr activates cell signalling and enhances muscle cell differentiation (Ceddia and Sweeney 2004; Louis et al. 2004;
Deldicque et al. 2007, 2008)
Cr lowers homocysteine levels and lipid peroxidation
(heart risk factors)
(Deminice et al. 2009)
Cr acts as an osmolyte, protecting cells against hypertonic stress (Alfieri et al. 2006)
PCr binds to cell membranes and stabilizes and protects erythrocyte cell
membranes
(Saks et al. 1996; Tokarska-Schlattner et al. 2003, 2005a)
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interesting compensatory alterations give new insight into
the kinds of problems that may have been generated in a
given tissue by knocking out of either cytosolic and/or
mitochondrial CK.
A further interesting observation relates to the fact that
CK exists as isoforms and that in a given cell usually a
cytosolic CK isoform is co-expressed with a mitochondrial
mtCK isoform, although the relative proportion may vary
depending on cell type and organ (Wallimann and Hemmer
1994). After knocking out one CK isoform only the other
CK isoform can at least partially compensate for the
function of the other, e.g. cytosolic CK can partially
compensate for mtCK (Watchko et al. 2000).
Muscle phenotypes of CK deficiency
The most obvious CK knockout phenotypes in muscle
relate (a) to force development and maintenance, as well
as force–velocity relationship, and (b) to muscle relaxation
and Ca2?-handling, as well as to (c) CK-mediated mem-
brane metabolic sensing. As to the first, transgenic mice
that are completely deficient in muscle CK lack burst
activity (van Deursen et al. 1993). The velocity and extent
of muscle shortening, power and work after the initial
series of stimuli are also significantly lower in the CK
knockouts compared to wild type (Watchko et al. 2000).
In transgenic mice with graded reduction of CK, muscle
burst activity is reduced proportionally to the lowered
levels of CK expression (van Deursen et al. 1994). These
data are in line with findings that MM-CK is specifically
localized at the M-band of sarcomeric muscle, where it
regenerates in situ the ATP used for muscle contraction
(Saks et al. 1984; Wallimann et al. 1984). In non-muscle
cells, ablation of BB-CK leads to altered actin-based
phagocytosis (Kuiper et al. 2008) and cell motility of cells
cultured from CK knockout animals (Kuiper et al. 2009),
indicating that CK is not only important for muscle con-
traction but also for phagocytosis and cell motility in
general. As to the second, in CK knockout muscle, muscle
relaxation time was longer, with changes also in intra-
cellular Ca2?-handling in transgenic muscle cells (Steeghs
et al. 1997). In line with earlier findings that CK is cru-
cially involved in local ATP regeneration in the vicinity of
the SR Ca2?-ATPase pump (Rossi et al. 1990), it was
shown with CK knockout mice that the CK system is
indeed essential for optimal refill of the SR Ca2? store in
skeletal muscle (de Groof et al. 2002). According to more
recent data, CK, however, is not only important for Ca2?
cycling in muscle, but also in the brain, as shown with
brain CK knockouts, where brain Ca2? kinetics were
affected (Streijger et al. 2010). Interestingly, Cr supple-
mentation of myogenic cells from mdx dystrophic mice
improves intracellular Ca2? handling (Pulido et al. 1998)
and Cr supplementation of athletes results in shortening of
muscle relaxation times in vivo, presumably by improving
SR-Ca2?-pump function and intracellular Ca2? handling
(van Leemputte et al. 1999). The fact that elevating total
Cr concentration in muscle by Cr supplementation of
human subjects leads to an increase in muscle force and to
faster muscle relaxation and recovery after exhaustive
exercise, compared with non-supplemented subjects (see
below), is fully in line with the described functions of the
CK isoforms. In addition, these data indicate that by Cr
supplementation, the efficiency of the respective subcel-
lular CK micro-compartments can be improved via ele-
vation of the PCr pool size. Finally, as to the third, by
transgenic deletion of cytosolic MM-CK the observed
integrative signalling through CK, where cellular ener-
getics is coupled to membrane metabolic sensing, is lost
(Abraham et al. 2002). This would corroborate the
importance of CK for metabolic sensing and signalling at
the plasma membrane.
Brain phenotypes of CK deficiency
Besides being expressed in all brain cells, real ‘‘hot spots’’
of CK expression and localization are Bergman glia and
Purkinje cells in the cerebellum that are important for
movement coordination and control, as well as neuronal
cells in the hippocampus, where learning and memory
functions reside, and finally epithelial cells in the choroid
plexus that are rich in ATP-dependent pumps for homeo-
stasis of ions and metabolites between the ventricular fluid/
brain interface (Wallimann and Hemmer 1994; Kaldis et al.
1996a). Accordingly, brain CK knockouts that present with
permanently reduced body weight, as well as with altered
brain morphology, display altered behaviour, e.g. low nest-
building activity, less exploratory activity, less grooming,
etc. and neurological difficulties in spatial learning and
memory functions (Jost CR et al. 2002; in ‘t Zandt et al.
2004; Streijger et al. 2005).
Recent data also show that the same animals present
with problems concerning thermoregulation, eventually
succumbing to a sudden and severe drop in body temper-
ature (Streijger et al. 2009). With respect to the involve-
ment of CK in thermoregulation, it is interesting to observe
that Cr supplementation in endurance athletes improved
their performance during exhausting exercise under hot
conditions. That is, in responders, whose muscle total Cr
increased during supplementation, rectal temperature
and heart rate lowered and peripheral key modulators and
indices for the brain neurotransmitters, serotonin and
dopamine, were influenced. The subjects in the Cr group
reacted with reduced effort perception and completed the
endurance task more easily compared to controls (Hadjic-
haralambous et al. 2008). At the same time, Cr reduced
1282 T. Wallimann et al.
123
inflammatory and muscle soreness markers after a 30 km
race (Santos et al. 2004).
Ablation of the genes for brain-type B-CK and ubiqui-
tous mtCK in mice also leads to frequency-dependent
hearing loss and problems with vestibular functions (Shin
et al. 2007), which is in line with the very high concen-
trations of CK found in the respective cellular structures of
the inner ear. Interestingly, Cr supplementation signifi-
cantly attenuated noise-induced hearing loss (Minami et al.
2007). Finally, brain CK knockout has demonstrated the
importance of CK for the energetics of bone metabolism
and osteoclast function for bone resorption (Chang et al.
2008). This complements earlier results concerning the
expression of CK in osteoblasts and the beneficial action of
Cr on survival, differentiation and mineralization of oste-
oblasts in culture (Gerber et al. 2005), as well as with the
stimulating effects of Cr on collagen type I synthesis and
osteoprotegerin secretion of healthy and osteoporotic
human osteoblasts (Gerber et al. 2008).
Thus, it seems obvious that CK takes over specific
functions in almost every cell of the body, except for liver,
where under normal healthy conditions no CK is expressed
(Wallimann and Hemmer 1994). Surprisingly, after the first
brain CK knockout transgenic mice became available, it
took almost 10 years to figure out some of the most
prominent phenotypes of this type of transgenic mice.
Probably, it will take another decade still to discover the
more subtle phenotypic changes, gone unnoticed, which
are caused by brain-type CK ablation.
Creatine—nutritional constituent and supplementation
Pleiotropic effects of creatine
Abrogation of CK enzymes in transgenic mice (see above)
or depletion of the substrate Cr in Cr-analogue-fed (GPA)
animals, respectively, both show muscle phenotypes with
similar functional deficits (Mekhfi et al. 1990; Wyss and
Wallimann 1994; O’Gorman et al. 1996, 1997b; Steeghs
et al. 1997, 1998). The affected functions, such as the
development of muscle force and muscle relaxation,
including intracellular Ca2? handling, can be enhanced in
wild-type animals, as well as in humans, by Cr supple-
mentation (Kraemer and Volek 1999; van Leemputte et al.
1999). These mostly energy-related ergogenic effects of Cr
in sports, based on the seminal work by Harris and Green-
haff in the early nineties (Harris et al. 1992; Greenhaff et al.
1993), are well known and in the meantime widely accepted
(Kamber et al. 1999). The same holds true for the effects of
Cr for rehabilitation (Hespel et al. 2001; Johnston et al.
2009) (Table 1). However, a number of potentially benefi-
cial effects of Cr, which are not directly related to
enhancement of cellular energetics, have emerged, for
example the protective effects of Cr on mitochondrial per-
meability transition pore opening (O’Gorman et al. 1997a;
Dolder et al. 2003), an early event in apoptosis, or the
antioxidant effects of Cr, as well as the interference of Cr
with cell signalling affecting the expression of muscle
transcriptional factors (Hespel et al. 2001; Hespel and
Derave 2007; Deldicque et al. 2008) or activating important
signalling pathways such a p38 Akt/PKB (Hespel et al.
2001; Deldicque et al. 2007; Hespel and Derave 2007;
Deldicque et al. 2008) or AMPK (Ceddia and Sweeney
2004) (Table 1).
Such beneficial effects of Cr may also alleviate toxic
drug effects that target bioenergetics and mitochondria,
such as the anti-cancer drug doxorubicin (Tokarska-Schl-
attner et al. 2002, 2006). Doxorubicin accumulates in
mitochondria and affects their functions including inhibi-
tion of CK isoforms (Tokarska-Schlattner et al. 2002;
Tokarska-Schlattner et al. 2005b, 2007). In an animal
study, Cr supplementation in combination with vitamins
was able to increase survival of doxorubicin-treated rats
(Santos et al. 2007).
The pleiotropic effects of Cr on muscle growth and
muscle performance have been documented in more than
400 publications to date. Cr has a scientifically unambig-
uously proven record of being a truly ergogenic nutritional
supplement that reaches the target organs, elevates muscle
total Cr and PCr pools, leads to an increase in muscle
mass and elevates muscle performance in a number of
sports (for reviews, see the position stands of the Inter-
national Society of Sports Nutrition: Buford et al. 2007;
Kerksick et al. 2008). The effects of Cr are most beneficial
for high-intensity intermittent exercise (Kraemer and
Volek 1999) but positive effects of Cr have also been
noted for better fatigue resistance (Rawson et al. 2011)
and for improved recovery after heavy exercise (Yquel
et al. 2002). It has also been realized that Cr could alle-
viate or spare muscle damage and inflammation caused by
excessive endurance performance experienced in an iron-
man competition (Bassit et al. 2008; see also Table 1). It
is important to note that the mostly anecdotal side effects
of Cr supplementation that are reported, e.g. via internet
can be dismissed on the basis of solid scientific evidence,
even if Cr is taken for extended periods of time (i.e.
years), (Kreider et al. 2003; Francaux and Poortmans
2006; Persky and Rawson 2007; Bender et al. 2008a).
However, the most relevant issue with respect to potential
side effects of Cr, namely the chemical purity of the Cr
used, is definitely an issue (Pischel and Gastner 2007).
Many of the pleiotropic effects of Cr for sports, health and
disease are discussed in detail in this volume. Here, we
would like to point out some potentially important new
applications of Cr supplementation and their potential
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socio-economic implications for humans and for the global
ecosystem.
Creatine supplementation for normal healthy people?
The protective effects of Cr as an adjuvant therapeutic
intervention in disease states, such as neuromuscular,
neuro-degenerative diseases, as well as muscle- and neuro-
rehabilitation, have been recently reviewed in a special
volume of ‘‘Subcellular Biochemistry’’ (‘‘Creatine and
Creatine Kinase in Health and Disease’’, edited by G. Salo-
mons and M. Wyss). In particular, the neuroprotective
role of Cr that is relevant to a number of neuromuscular
and neuro-degenerative diseases is well documented
(Matthews et al. 1998; Klivenyi et al. 1999; Brewer and
Wallimann 2000; Wyss and Kaddurah-Daouk 2000; Baker
and Tarnopolsky 2003; Andres et al. 2005a, b; Brosnan and
Brosnan 2007; Rodriguez et al. 2007; Tarnopolsky 2007;
Adhihetty and Beal 2008; Andres et al. 2008; Valastro
et al. 2009; Gualano et al. 2010).
Little has been mentioned so far of the potential benefits
of Cr supplementation for normal healthy people. In a
placebo-controlled, randomized animal study, it was shown
in fact that life-long Cr supplementation, even at very high
daily dosage, is of significant benefit to life expectancy and
most importantly also for life quality of normal healthy
mice (Bender et al. 2008a). In a recent study with human
subjects, glucose tolerance in healthy sedentary males
undergoing aerobic training was improved by Cr supple-
mentation. Thus, a change in life-style together with intake
of Cr may prevent or delay the onset of health problems,
such as type-2 diabetes, obesity and metabolic syndrome
(Gualano et al. 2008a).
Cr supplementation, in conjunction with exercise, was
shown to improve muscle performance in elderly men and
postmenopausal women (Gotshalk et al. 2002, 2008), as
well as to increase bone mineral density in healthy elderly
men (Chilibeck et al. 2005). This is in line with the findings
that Cr increases survival, metabolic activity, as well as
mineralization of cultured osteoblast cells in vitro (Gerber
et al. 2005). Thus, Cr may not only be beneficial for muscle
but also for bone health of normal healthy people. It is
entirely conceivable that Cr supplementation could allevi-
ate or prevent osteopenia and/or osteoporosis of postmen-
opausal women (Gerber et al. 2005, 2008), as Cr has been
shown to stimulate collagen type I synthesis and secretion
of osteoprotegerin in human bone cells derived from
osteopenic subjects (Gerber et al. 2008).
Positive effects of Cr supplementation on memory,
learning and mental performance (Rae et al. 2003), as well
as on cognitive performance, have been demonstrated
(McMorris et al. 2007), and a reduction of mental fatigue
by Cr was also shown (Watanabe et al. 2002).
Creatine for the elderly?
A simple and inexpensive intervention, a daily supple-
mentation with 2–5 g of chemically pure Cr for healthy
adults and most importantly for senior and elderly people
(Gotshalk et al. 2002, 2008), is likely to contribute as a
preventive measure to muscle, bone and brain health,
potentially saving billions of dollars otherwise spent for
rehabilitation measures following accidents (Hespel and
Derave 2007; Dalbo et al. 2009). Cr supplementation
seems especially relevant for elderly, who often eat much
less or no meat at all and thus likely have low tissue Cr
levels, as limited data from vegans and vegetarians indi-
cates (Burke et al. 2003; Watt et al. 2004). Recent nutri-
tional recommendations by the US Society for Sarcopenia,
Cachexia and Wasting Disease proposed Cr supplementa-
tion together with other measures for the management of
sarcopenia (age-dependent progressive muscle loss) which
is prevalent among the elderly (Morley et al. 2010).
Interestingly, 2 weeks of 4 9 5 g of Cr daily improved
cognitive performance in the elderly (McMorris et al.
2007). With respect to the possible beneficial effects of Cr
supplementation that have been discussed for elderly
(Dalbo et al. 2009), it is important to note that Cr acts as an
osmolyte. Since Cr is taken up by the osmotically active
sodium and chloride dependent CRT, concomitant import
of NaCl into the target cells may lead to at least a tem-
porary increase in the intracellular water content (Ziegen-
fuss et al. 1998). Hydration is an important physiological
parameter in humans that gradually decreases with age
(Aloia et al. 1998). However, in order to substantiate these
preliminary results, many highly relevant to disease pre-
vention and potentially with significant socio-economical
health benefits, multi-centre epidemiological studies
involving hundreds or thousands of subjects over pro-
longed periods of time would be necessary. Such studies
would be expensive undertakings. However, as Cr promises
only negligible financial returns to pharmaceutical compa-
nies, such studies would most likely have to be funded by
government agencies.
Creatine as a prominent nutritional constituent
for man since prehistoric times
Concerning possible health benefits for healthy people, a
legitimate question that may be asked is whether modern
man, due to greatly changed eating habits, is justified in
supplementing the diet with additional Cr particularly
when this can be synthesised endogenously and obtained
through a balanced meat and fish diet. To possibly answer
this question we need to examine early hominid nutrition.
A recent archaeological survey in Ethiopia brought to light
stone-tool inflicted cut and percussion marks on ungulate
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bones that were dated to older than 3.39 million years.
These, the oldest findings of this kind, after careful
microscopic examination were identified as being the result
of early hominid stone tools used for removing flesh from
bones and for retrieving bone marrow (McPherron et al.
2010). These findings indicate that Australopithecus afar-
ensis already practised butchery of large animals and
consumed meat some 3.4 million years ago.
Humans have clearly evolved as carnivores/omnivores,
ingesting large quantities of meat and fish, and thus
necessarily also Cr, as a significant part of their diet
(Broadhurst et al. 1998; Richards 2002). There is evi-
dence that evolutionarily human brain development and
growth were strongly dependent on the availability of
high-quality food, such as meat and/or fish, representing
nutritionally rich sources of protein, fatty acids, vitamins
and minerals (Milton 2003) and incidentally also of Cr.
Evidence from isotopic analysis of skeletons of Nean-
derthals and modern Palaeolithic and Mesolithic humans
highlights the importance of meat and fish in the hominid
diet (Richards 2002). When successful at hunting or
fishing, these hominids as true carnivores/omnivores, most
likely devoured more than 1–2 kg of meat or fish per day
during prolonged periods of time during the year,
ingesting at least 5–10 g or more of Cr daily. The com-
bination of high-quality diet and the higher proportion of
maternal daily energy budget invested in the growing
embryo during pregnancy of prehistoric women, would
additionally have allowed for greater body weight as well
as larger brain size (encephalization) relative to body
weight of the infant at birth, compared with other pri-
mates (Ulijaszek 2002; Carlson and Kingston 2007). With
respect to Cr, it is known that endogenous synthesis of Cr
is energetically costly in terms of methyl-group equiva-
lents. Carnivores/omnivores ingesting large amounts of Cr
thus spare a significant proportion of the energy needed
for acquisition of reactive methyl group equivalents in the
form of S-adenosyl-L-methionine (AdoMet) that can be
used for other anabolic synthetic pathways (Brosnan et al.
2007a, b).
It, therefore, seems that the evolutionary path of homi-
nid development is tightly linked to food quality, e.g. to
ingesting large amounts of meat and fish and concomitantly
also of Cr. One might surmise from this that Cr supple-
mentation should also belong to the nutritional require-
ments of modern man, depending on how much meat and/
or fish is actually ingested daily. Depending on the cultural
and economic background, the present daily meat con-
sumption varies from zero (vegans) to approximately 150 g
(Switzerland) or 250–300 g (USA, Australia) of meat/
person/day (numbers include not only fresh but also pro-
cessed meat that is known to contain much less Cr than
fresh meat, or even none at all). These numbers correspond
to a daily Cr consumption per person from zero to about
0.75–1.5 g and are clearly at the lower end of daily ali-
mentary requirements for Cr that may be in the order of
2–4 g/person/day (see European Food Safety Authority
web site: http://www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620761727.htm).
Finally, the fact that in most people who ingest extra Cr
the total Cr pool size (Cr ? PCr) in muscle is elevated by
5–20% indicates that in these the Cr pools are not satu-
rated. This alone could be taken as an argument that even
normal healthy people should supplement with Cr. The fact
that meat consumption is recommended to be lowered
globally for health (cf. high cholesterol, etc.) and ecological
reasons lends additional support to the argument for Cr
supplementation of the diet.
Foetal creatine metabolism and supply
during pregnancy
Using a special precocial mouse strain, the spiny mouse
(Acomys cahirinus) with a longer pregnancy than that of
normal mice, closely resembling human pregnancy, it was
convincingly shown that Cr supplementation protects the
brain of the mouse pups in vivo against hypoxia and thus
significantly enhances survival of the offspring (Ireland
et al. 2008). This corroborates earlier findings that Cr
protects the brain of newborn rats against hypoxia (Adcock
et al. 2002) or of adult mice in a model of stroke (Prass
et al. 2007). Also, Cr displayed astonishingly positive
effects in traumatic brain injury in animals (Sullivan et al.
2000; Hausmann et al. 2002), as well as in children and
adolescent patients (Sakellaris et al. 2006). Maternal Cr
supplementation from mid-pregnancy onwards has most
recently been shown to protect the diaphragm of the
newborn spiny mouse from intra-partum hypoxia-induced
damage (Cannata et al. 2010).
What is new in the spiny mouse study is the fact that
pregnant dams were fed Cr. This orally fed Cr is actively
transported into the foetus via placental CRT (Ireland et al.
2009). Cr supplementation of the pregnant dam leads to an
enhancement of total Cr levels in most organs, not only of
the mother but also of the embryo, including the brain and
thus protects the precocial mouse pups from episodes of
hypoxia during a simulated hypoxic birth (Ireland et al.
2008; Cannata et al. 2010). These are important findings
indicating that Cr supplementation during pregnancy may
be a general protective measure to lower the incidence of
brain damage and enhance survival also of human babies
that go through periods of anoxia during birth or are at
high-risk for an ischemic/anoxic birth to start with. Thus, it
is entirely conceivable that the protective effects of Cr that
are observed with experimental animals will also hold true
for humans.
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In line with this hypothesis is the fact that endogenous
Cr synthesis in the spiny mouse foetus gradually develops,
but only reaches a mature level some time after birth
(Ireland et al. 2009). The placenta expresses relatively high
amounts of Cr transporter (CRT) and the expression of
CRT in the placenta is high during the entire pregnancy and
increases even more before birth (Ireland et al. 2009). This
indicates that a significant part of embryonic Cr is taken up
via the placenta and endogenous Cr synthesis in the foetus
is not yet fully established. Thus, it can be concluded that
the spiny mouse foetus depends on Cr delivered by the
mother via her placenta. Although Cr is basically free of
significant side effects, the dosage of Cr, used in the
experiments with spiny mice described above, was very
high with 5%, (w/w) in the food. This amounts, depending
on how much food a pregnant mouse consumes, to an
equivalent of 20–50 g of Cr or more per day for an adult
human. This, on the other hand, demonstrates that Cr is
safe also at high dosages, even for the foetus, which is in
line with a study using Cr supplementation for premature
babies in a clinical set-up, where no serious side effects of
Cr had been observed in preterm babies (Bohnhorst et al.
2004).
In addition to the obvious benefits of Cr for the baby, Cr
supplementation of the mother during pregnancy could
additionally be of benefit for the build-up of a strong uterus
during the third trimester, when the uterus energetically
matures by implementing the CK system (Dawson and
Wray 1985; Clark et al. 1993; Clark 1994; Wallimann and
Hemmer 1994). This could help to ease birthing, which
largely depends on the energy charge of uterine smooth
muscle and thus also of the PCr pool size (Kumar et al.
1962), to develop sufficient muscle force for the expulsion
of the embryo. Therefore, it may be legitimate to propose
that Cr supplementation should be a standard regimen
during pregnancy, as well as after birth, both for the
pregnant and lactating mother, as well as for the baby. This
would favour healthy brain development of the embryo and
baby, as it is obvious that Cr-deficient patients suffer from
severe developmental delay with accompanying mental
retardation (Schulze 2003).
Creatine as natural constituent of mother’s milk
Human colostrums and milk contain significant concen-
trations of Cr, in the range of 0.2 mM (Hulsemann et al.
1987; Peral et al. 2005). The same is true for cow and sow
milk with approximately 0.8 mM Cr (Sheffy et al. 1952;
Hulsemann et al. 1987; Peral et al. 2005). Interestingly, in a
detailed study on sow colostrums and milk throughout
lactation and weaning, both Cr and PCr were identified at
up to 1.5 and 1.2 mM concentrations, respectively (Ken-
naugh et al. 1997). It seems that Cr values can vary
significantly, depending on the analytical techniques used.
In addition, the variation found in the absolute Cr values
and the Cr/Crn ratio may indicate that not always fresh
milk was analysed. Using non-destructive NMR methods
and spectral peak assignments, however, a prominent
proton NMR peak was identified as Cr in bovine milk (Hu
et al. 2004), thus leaving no doubt that Cr is a genuine
chemical constituent in fresh milk. It would be of impor-
tance to investigate in detail whether and how nutrition
would influence the total Cr content in mother’s milk.
A 3- to 4-month-old baby of 5 kg consumes approxi-
mately 800 ml milk per day from the mother at 0.2 mM Cr,
or from cow milk, at 0.8 mM Cr (Hulsemann et al. 1987),
amounting to a Cr ingestion of 4 or 16 mg Cr/kg body
weight per day, respectively, which translates into
approximately 0.3 or 1.2 g of Cr per day, respectively, for
an adult person. Considering the fact that a significant
amount of creatinine (25% in cow milk and more than 50%
in human milk) was also found that may have arisen from
Cr break-down during pasteurization of the milk, one can
assume the above values to be lower-limit estimates, such
that the actual Cr in fresh milk and, concomitantly, also the
Cr intake by infants would be higher by a factor of 2–3 if
really fresh milk were consumed.
Creatine supplementation of the mother
during pregnancy, and of baby formulas
and infant nutrition?
Cr is secreted by the mammary gland during lactation and
has been shown to be absolutely required for normal brain
development and brain function (see Wyss and Schulze
2002). According to recent data from rats, the rat mammary
gland of dams does not synthesize the Cr to be secreted but
is extracted from the circulation (Lamarre et al. 2010).
Since there was no increase in endogenous Cr synthesis in
the dams, this required an increase for the lactating mother
of approximately 50% in alimentary Cr above the normal
daily requirement. In rats, this is largely compensated by
hyperphagia, as normal rat feed contains Cr that is intro-
duced by dried meat and fish products (Lamarre et al.
2010). This suggests that pregnant, and even more so lac-
tating mothers, who remain vegans or vegetarians during
pregnancy and lactation, may suffer from an inadequate
supply of Cr, which in turn may not be favourable for the
development of the foetus and infant when nursing.
In the above work, it was further shown that while Cr is
substantially accumulated in the growing pups, only 12%
of this was obtained from the mother’s milk (Lamarre et al.
2010). Thus, the relatively high need for Cr in the rat pups
clearly places a metabolic burden on them, since, as
mentioned earlier, endogenous Cr synthesis is energy
costly and may use as much as 40% of the total SAM
1286 T. Wallimann et al.
123
available for trans-methylation reactions (Brosnan and
Brosnan 2007; Brosnan et al. 2007a, b). If this is also true
for humans (Mudd et al. 2007), the legitimate question
arises, as to whether supplementing lactating women with
Cr and thus have them secrete more Cr into their mothers
milk may relieve some of the metabolic burden of energy-
costly endogenous Cr synthesis by the baby. The same
would hold true with respect to supplementing baby food
and infant nutrition with Cr in non-nursing mothers or after
weaning.
Except for soy-based baby milk, which is devoid of Cr,
most of the baby formulas and follow-up baby nutrition
preparations were found to contain Cr and Crn in a similar
concentration range (0.3 and 0.1 mM, respectively) as
mother’s milk, although with significant variations (Hul-
semann et al. 1987). Thus, pending more thorough inves-
tigations, it may turn out to be advisable to control and
eventually supplement not only purely vegetarian soy-based
baby food, but also all infant nutrition products, with Cr.
Interesting in this context is the fact that it was already
noted in 1913 that ‘‘the increase in body weight of a baby
after birth was roughly proportional to the Cr excreted in the
urine by the respective mothers and that the excreted Cr/Crn
ratio of the urine increased proportionally with mammary
gland activity’’ (Mellanby 1913). Thus Cr, be it delivered via
mothers milk or supplemented externally, seems generally
beneficial for growth and development of the infant.
Since Cr is definitely an important constituent in milk of
mammals, including humans, it is hard to understand that
there still exist baby formulas and early infant nutrition
products, especially products based entirely on soy-bean,
which do not contain any or only very little Cr. Changing
this situation should be a high priority of International and
European Child Nutrition Advisory Boards, and this should
be an important focus of Cr research during the coming
years. The socio-economic benefit of this and other Cr
supplementation applications, e.g. for general skeleto-
muscular- (Tarnopolsky 2007) and neuro-rehabilitation
(Sakellaris et al. 2006) seems obvious since every infant
spared from irreversible brain damage caused for example
by ischemia/anoxia during a difficult birth (Adcock et al.
2002; Ireland et al. 2008, 2009; Cannata et al. 2010) is
beyond reckoning, not to speak of the relief from suffering.
The objection that Cr could have side effects on human
babies and infants has no scientific foundation. In a recent
clinical study with premature infants, who were given
200 mg of Cr per kg body weight per day for 2 weeks, a
dose corresponding to 14 g of Cr per day for an adult
person of 70 kg, the treatment was well tolerated and no
side effects were noted (Bohnhorst et al. 2004). However,
there is an urgent need of clinically controlled studies in
the field to determine a physiologically acceptable Cr dose
for use with infants.
Children with a so-called Cr-deficiency syndrome, who
have genetic defects either in one of the enzymes for
endogenous Cr synthesis (AGAT or GAMT), or in the
CRT, present with severe neurological symptoms, such as
developmental and speech delay, mental retardation, aut-
ism and epilepsy (Schulze 2003), which is largely due to
the complete absence of Cr in brain tissue. This emphasises
the importance of Cr for normal brain development and
function (Newmeyer et al. 2005) and, by implication,
advocates the adoption of Cr supplementation for pregnant
women, as well as for preterm babies and infants. It seems
of utmost importance that Cr in infant food is recognized as
an essential component of human nutrition and that its
content in infant formulas should be mandatorily regulated
and controlled.
Finally, the clinical tests (from urine and blood) for
Cr-deficiency should be mandatory for all newborns. By
this strategy, infants with treatable Cr-deficiencies
(in AGAT or GAMT, but not in CRT) could be helped to
lead a normal life.
Creatine supplementation of parenteral nutrition?
Individuals, who are supported in intensive care units
(ICU), as well as severely ill patients with a variety of
disease states, e.g. cancer patients with cachexia, fully
depend on parenteral food which ideally should include
supplementary Cr if needs are to be met. Unfortunately, Cr
has not yet been recognized as a nutrient to be included in
parenteral food. In this way, atrophy of muscles, particu-
larly intra-costal muscles and diaphragm, could be lessened
in IUC patients that are supported by artificial ventilation.
The longer artificial ventilation is implemented, the more
difficulties such patients experience in resuming indepen-
dent breathing. Since Cr has been shown to significantly
alleviate muscle disuse atrophy (Johnston et al. 2009), it is
to be expected that resumption of breathing and rehabili-
tation of ICU patients may also be positively influenced by
Cr. The same, of course, holds true for severely ill patients
presenting with cachexia, as often occurs for cancer
patients. Parenteral supplementation with Cr would help to
prevent the physiological sequelae of Cr depletion to be
expected in such patients (Wyss and Wallimann 1994).
Creatine for dialysis patients?
As pointed out earlier, Cr is not toxic to the kidney but
rather is important for kidney function itself, since the CK/
PCr system supports ion-pumps and metabolite transporters
in this organ that are responsible for ion balance and
resorption of metabolites from the urine. Patients with
chronic renal failure (CRF) undergoing dialysis, who for
obvious reasons are advised to restrict meat consumption,
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may present after a certain time with an altered skeletal and
cardiac muscle energy metabolism, being low or deficient
in Cr and showing a low PCr/ATP ratio (Pastoris et al.
1997; Tagami et al. 1998; Ogimoto et al. 2003). It is known
that these patients lose muscle mass, become weaker and
experience chronic fatigue. For these reasons, supplemen-
tation of dialysis patients with Cr might be viewed as an
adjuvant therapy that should be implemented for counter-
acting some of the side effects of prolonged dialysis. An
elegant method for Cr supplementation of this group of
patients, undergoing either peritoneal or haemodialysis,
would be to add appropriate amounts of Cr directly into the
dialysis fluid. This would ease compliance and spare the
patients to have to orally ingest yet another powder besides
phosphate and calcium binders, etc. In the only study so
with dialysis patients, involving the very limited number of
five patients, oral Cr supplementation reduced spastic
muscle cramps, a problem often observed in these patients
(Chang et al. 2002).
Creatine as feed additive for animal nutrition, growing
life stock and aquaculture?
Endogenous synthesis of Cr is energy-costly and consumes
some 40% of the SAM available for methylation reactions
(Brosnan et al. 2007a, b, 2009). In addition, the three
amino acids needed for Cr synthesis, arginine, glycine and
methionine are valuable and some are ‘physiologically’
expensive. By including chemically synthesised Cr in a
pure form in animal feeds, these amino acids would be
spared for protein synthesis and growth. This holds true
also for processed and dry pet food, which compared with
fresh meat and offal contains very little Cr (Harris et al.
1997), such that supplementation with Cr of pet food would
make sense.
Chickens fed during a growing period of 41 days with
an entirely vegetable soy-based feed, to which 0.2% w/w of
pure Cr was added, show a 4% greater body weight gain
compared with chickens fed with normal meat- and fish-
meal containing feed. In addition, feed consumption in the
Cr group decreased by 2–3% and the weight gain was
shown to be due to growth of lean muscle mass (Pfirter and
Wallimann, unpublished data). Thus, Cr may have signif-
icant potential as an additive for animal feed, replacing
millions of tons of meat- and fish-meal for animals, as well
as for fish aquaculture. On a global scale, this could help
with problems of world hunger and the prevention of over-
fishing of oceans for fish-meal production. Interestingly Cr
supplementation of Drosophila melanogaster, known to
express arginine kinase (AK) instead of CK (Wallimann
and Eppenberger 1973), protects these flies from oxidative
stress caused by exposure to rotenone, a potent mitochon-
drial toxin, and paraquat, a potent herbicidal redox cycler,
that both generate ROS (Hosamani et al. 2010). Since these
insects are not able to phosphorylate Cr into PCr, the
protective effects of Cr observed cannot be due to
improved cellular energetics, but are more likely related to
anti-oxidant and/or anti-apoptotic effects of this guanidino
compound. Thus Cr may be added to animal feed as a
protectant also against environmental oxidative and toxic
stress.
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Appendix
For a general update in the field, see the recently published
books:
– Saks VA (ed) (2007) Molecular systems bioenergetics:
energy for life. Wiley–VCH, Weinheim.
– Salomons GS, Wyss M (eds) (2007) Creatine and
creatine kinase in health and disease. Subcellular
Biochemistry, vol 46. Springer, Dordrecht.
– Vial C (ed), Uversky VN (series ed) (2006) Creatine
kinase—biochemistry, physiology, structure and func-
tion. Nova Science Publishers, New York.
Note added in proof After this review had been submitted some
most recent clinically relevant publications have appeared which are
fully supporting the views on the multiple beneficial actions of
creatine supplementation expressed in the review presented here.
From the number of most recent publications in the field, plus those
appearing in the present special volume of the Journal ‘‘Amino
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Acids’’, it seems that both basic and especially also clincial research
on the pleiotropic functions of creatine is gaining momentum again.
Some of these publications are listed as references below.
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